Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Schizophrenia Market Size Changed, over the years?
In recent times, there has been a robust growth in the market size of schizophrenia. This market is projected to expand from $5.82 billion in 2024 to $6.11 billion in 2025, registering a compound annual growth rate (CAGR) of 5.0%. Factors contributing to this growth during the historic period include an increased demand for effective treatments, heightened awareness about mental health, government programs, and a rise in research and development activities.
How Much Will the Schizophrenia Market Be Worth in 2029?
The market size for schizophrenia is anticipated to witness robust expansion in the coming years. It is projected to escalate to $7.54 billion in 2029, with a 5.4% compound annual growth rate (CAGR). The predicted growth during this forecasted duration is due to the rise in personalized medicine, increased digital health solutions, improved antipsychotic medications, and widened healthcare service accessibility. Key trends during the forecast period comprise the development of new drugs, heightened focus on early intervention, recovery-oriented healthcare, and an enlarging clinical trials pipeline for treatments targeting schizophrenia.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12869&type=smp
Which is the Largest Company in the Schizophrenia Market?
Major companies operating in the schizophrenia market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Amgen Inc., Otsuka Holdings Co. Ltd., Biogen Inc., Daiichi Sankyo Co. Ltd., Astellas Pharma Inc., Sumitomo Dainippon Pharma Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Recordati SpA, Lundbeck A/S, Neurocrine Biosciences Inc., Torrent Pharmaceutical Ltd., Alkermes PLC, Indivior PLC, Vanda Pharmaceuticals Inc., Intra-Cellular Therapies Inc., Axsome Therapeutics Inc., PsychoGenics Inc., Karuna Therapeutics Inc., Minerva Neurosciences Inc.
What Are the Main Market Drivers in the Schizophrenia Industry?
The anticipated surge in mental disorder cases is set to fuel the expansion of the schizophrenia market. Mental disorders entail a spectrum of conditions affecting an individual’s thought process, feelings, mood, and behavior. These conditions significantly interfere with a person’s daily life and ability to connect with others. The escalating number of mental disorder incidences has spurred advancements in schizophrenia remedies and the invention of novel drugs, leading to market expansion. In March 2023, the National Institute of Mental Health (NIMH), a department under the US’s Health and Human Services, reported that around 57.8 million people aged 18 and above had some form of mental illness (AMI), accounting for 22.8% of all US adults. The highest prevalence of AMI was amongst young adults, aged 18-25 years (33.7%), followed by the 26-49 years age group (28.1%) and those over 50 (15.0%). Thus, the mounting mental health issue prevalence accelerates the growth of the schizophrenia market. An escalating need for anxiety therapy is set to boost the schizophrenia market’s growth. Anxiety therapy encompasses various strategies and interventions designed to assist those struggling with intense, debilitating anxiety symptoms in managing and reducing their anxiety. Anxiety therapy can greatly benefit schizophrenia patients by managing the frequent anxiety symptoms that co-exist with schizophrenia and reducing the severity of psychotic symptoms like hallucinations and delusions. According to a May 2024 report by the American Psychiatric Association, a psychologists’ professional organization in the US, 43% of adults felt more anxious in 2024 than 37% in 2023 and 32% in 2022, demonstrating a steady rise in anxiety levels. Consequently, the escalating need for anxiety therapy stimulates the expansion of the schizophrenia market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12869&type=smp
How Is the Schizophrenia Market Segments Structured?
The schizophrenia market covered in this report is segmented –
1) By Type: Catatonic Schizophrenia, Paranoid Schizophrenia, Undifferentiated Schizophrenia, Hebephrenic Schizophrenia, Residual Schizophrenia, Other Types
2) By Treatment: First-Generation Antipsychotics, Second-Generation Antipsychotics, Third-Generation Antipsychotics, Psychotherapies, Other Treatments
3) By Route of Administration: Oral, Injectables
Subsegments:
1) By Catatonic Schizophrenia: Waxy Flexibility, Stupor, Agitation, Catatonic Excitement
2) By Paranoid Schizophrenia: Delusions Of Persecution, Auditory Hallucinations, Paranoid Ideation
3) By Undifferentiated Schizophrenia: Symptoms Not Specific To Other Types, Mixed Symptoms Of Schizophrenia
4) By Hebephrenic Schizophrenia (Disorganized Schizophrenia): Disorganized Behavior, Disorganized Speech, Emotional Flatness
5) By Residual Schizophrenia: History Of Schizophrenia With Low-Level Symptoms, Social Withdrawal, Mild Hallucinations Or Delusions
6) By Other Types: Schizoaffective Disorder, Brief Psychotic Disorder, Delusional Disorder
What Strategic Trends Are Transforming the Schizophrenia Market?
Leading firms in the schizophrenia market are leveraging innovative technologies, such as automated psychological therapy, to reinforce their market standing. Automated psychological therapy involves the employment of technology like virtual reality (VR) to offer psychological therapy either automatically or on a self-guided basis. For example, in April 2022, OxfordVR Limited, a digital therapeutic corporation based in Switzerland, introduced the gameChangeVR technology, a 6-week automated VR regimen which imparts cognitive behavioral therapy (CBT) in secure, comprehensive virtual environments. VR-aided automated psychological therapy caters to individuals suffering from mental disorders, with a virtual coach replacing a physical therapist, thereby enabling the therapy to benefit a larger number of patients. This marks the inaugural instance of digital therapy proving effective in treating individuals suffering from schizophrenia and mood disorders with psychotic symptoms.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/schizophrenia-global-market-report
Which Global Regions Offer the Highest Growth in the Schizophrenia Market?
North America was the largest region in the schizophrenia market in 2024. The regions covered in the schizophrenia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12869
This Report Delivers Insight On:
1. How big is the schizophrenia market, and how is it changing globally?
2. Who are the major companies in the schizophrenia market, and how are they performing?
3. What are the key opportunities and risks in the schizophrenia market right now?
4. Which products or customer segments are growing the most in the schizophrenia market?
5. What factors are helping or slowing down the growth of the schizophrenia market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model